Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 13/20 | 0.37 |
| ▸ | BCHE | P06276 | 12/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1173441 | 0.73 | ACHE (0.34) | ACHEBCHE | |
| SCHEMBL4109076 | 0.72 | KCNH2 (0.53) | APPKCNH2 | |
| SCHEMBL1185247 | 0.71 | ACHE (0.42) | ACHEBCHE | |
| Perchlorate SCHEMBL4340826 | 0.67 | KCNH2 (0.47) | APPKCNH2 | |
| Diphenylacetylene SCHEMBL14354086 | 0.67 | APP (0.71) | APPKCNH2 | |
| SCHEMBL4108606 | 0.66 | APP (0.33) | APPKCNH2 | |
| Diphenylacetylene SCHEMBL8751747 | 0.66 | APP (0.80) | APPKCNH2 | |
| SCHEMBL4107007 | 0.66 | APP (0.52) | APPKCNH2 | |
| SCHEMBL1665979 | 0.63 | ACHE (0.46) | ACHEBCHE | |
| Diphenylacetylene SCHEMBL29188592 | 0.62 | APP (1.00) | APPKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7611546-B2 | Composition comprising at least one substituted acetylenic carbocyanin derivative, process for treating keratin fibres using it, and device therefor | L'OREAL S.A. (FR) | 2009-11-03 | — | — | US | disclosed |
| US-20090064423-A1 | Composition comprising at least one substituted acetylenic carbocyanin derivative, process for treating keratin fibres using it, and device therefor | L'OREAL S.A. (FR) | 2009-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090064423-A1 | Composition comprising at least one substituted acetylenic carbocyanin derivative, process for treating keratin fibres using it, and device therefor | KRT18, HADHB, KAT7 | APP 2158/4885ACHE 540/4885BCHE 538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.